Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-145191)

Filing Details

Accession Number:: 0001104659-16-145191
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-16 17:00:51
Reporting Period:: 2016-09-14

Filing Date:: 2016-09-16
Accepted Time:: 2016-09-16 17:00:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157602	Vitae Pharmaceuticals Inc	VTAE	Pharmaceutical Preparations (2834)	043567753

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1609879	S. Jeffrey Hatfield	C/O Vitae Pharmaceuticals, Inc. 502 West Office Center Dr. Fort Washington PA 19034	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-14	50,000	$20.81	244,996	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015.